Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease

Jon B Toledo,Maria Bjerke,Xiao Da,Susan M Landau,Norman L Foster,William Jagust,Clifford Jack Jr,Michael Weiner,Christos Davatzikos,Leslie M Shaw,John Q Trojanowski,Alzheimer’s Disease Neuroimaging Initiative Investigators,Paul Aisen,Ronald Petersen,Clifford R Jack Jr,John Q Trojanowki,Arthur W Toga,Laurel Beckett,Robert C Green,Andrew J Saykin,John Morris,Enchi Liu,Tom Montine,Anthony Gamst,Ronald G Thomas,Michael Donohue,Sarah Walter,Devon Gessert,Tamie Sather,Danielle Harvey,John Kornak,Anders Dale,Matthew Bernstein,Joel Felmlee,Nick Fox,Paul Thompson,Norbert Schuff,Gene Alexander,Charles DeCarli,Dan Bandy,Robert A Koeppe,Norm Foster,Eric M Reiman,Kewei Chen,Chet Mathis,Nigel J Cairns,Lisa Taylor-Reinwald,Les Shaw,Virginia M Y Lee,Magdalena Korecka,Karen Crawford,Scott Neu,Tatiana M Foroud,Steven Potkin,Li Shen,Zaven Kachaturian,Richard Frank,Peter J Snyder,Susan Molchan,Jeffrey Kaye,Joseph Quinn,Betty Lind,Sara Dolen,Lon S Schneider,Sonia Pawluczyk,Bryan M Spann,James Brewer,Helen Vanderswag,Judith L Heidebrink,Joanne L Lord,Kris Johnson,Rachelle S Doody,Javier Villanueva-Meyer,Munir Chowdhury,Yaakov Stern,Lawrence S Honig,Karen L Bell,John C Morris,Beau Ances,Maria Carroll,Sue Leon,Mark A Mintun,Stacy Schneider,Daniel Marson,Randall Griffith,David Clark,Hillel Grossman,Effie Mitsis,Aliza Romirowsky,Leyla deToledo-Morrell,Raj C Shah,Ranjan Duara,Daniel Varon,Peggy Roberts,Marilyn Albert,Chiadi Onyike,Stephanie Kielb,Henry Rusinek,Mony J de Leon,Lidia Glodzik,Susan De Santi,P Murali Doraiswamy,Jeffrey R Petrella,R Edward Coleman,Steven E Arnold,Jason H Karlawish,David Wolk,Charles D Smith,Greg Jicha,Peter Hardy,Oscar L Lopez,MaryAnn Oakley,Donna M Simpson,Anton P Porsteinsson,Bonnie S Goldstein,Kim Martin,Kelly M Makino,M Saleem Ismail,Connie Brand,Ruth A Mulnard,Gaby Thai,Catherine McAdams-Ortiz,Kyle Womack,Dana Mathews,Mary Quiceno,Ramon Diaz-Arrastia,Richard King,Myron Weiner,Kristen Martin-Cook,Michael DeVous,Allan I Levey,James J Lah,Janet S Cellar,Jeffrey M Burns,Heather S Anderson,Russell H Swerdlow,Liana Apostolova,Po H Lu,George Bartzokis,Daniel H S Silverman,Neill R Graff-Radford,Francine Parfitt,Heather Johnson,Martin R Farlow,Ann Marie Hake,Brandy R Matthews,Scott Herring,Christopher H van Dyck,Richard E Carson,Martha G MacAvoy,Howard Chertkow,Howard Bergman,Chris Hosein,Sandra Black,Bojana Stefanovic,Curtis Caldwell,Ging-Yuek Robin Hsiung,Howard Feldman,Benita Mudge,Michele Assaly,Andrew Kertesz,John Rogers,Dick Trost,Charles Bernick,Donna Munic,Diana Kerwin,Marek-Marsel Mesulam,Kristina Lipowski,Chuang-Kuo Wu,Nancy Johnson,Carl Sadowsky,Walter Martinez,Teresa Villena,Raymond Scott Turner,Kathleen Johnson,Brigid Reynolds,Reisa A Sperling,Keith A Johnson,Gad Marshall,Meghan Frey,Jerome Yesavage,Joy L Taylor,Barton Lane,Allyson Rosen,Jared Tinklenberg,Marwan Sabbagh,Christine Belden,Sandra Jacobson,Neil Kowall,Ronald Killiany,Andrew E Budson,Alexander Norbash,Patricia Lynn Johnson,Thomas O Obisesan,Saba Wolday,Salome K Bwayo,Alan Lerner,Leon Hudson,Paula Ogrocki,Evan Fletcher,Owen Carmichael,John Olichney,Smita Kittur,Michael Borrie,T-Y Lee,Rob Bartha,Sterling Johnson,Sanjay Asthana,Cynthia M Carlsson,Steven G Potkin,Adrian Preda,Dana Nguyen,Pierre Tariot,Adam Fleisher,Stephanie Reeder,Vernice Bates,Horacio Capote,Michelle Rainka,Douglas W Scharre,Maria Kataki,Earl A Zimmerman,Dzintra Celmins,Alice D Brown,Godfrey D Pearlson,Karen Blank,Karen Anderson,Robert B Santulli,Eben S Schwartz,Kaycee M Sink,Jeff D Williamson,Pradeep Garg,Franklin Watkins,Brian R Ott,Henry Querfurth,Geoffrey Tremont,Stephen Salloway,Paul Malloy,Stephen Correia,Howard J Rosen,Bruce L Miller,Jacobo Mintzer,Crystal Flynn Longmire,Kenneth Spicer,Elizabether Finger,Irina Rachinsky,Dick Drost,Nunzio Pomara,Raymundo Hernando,Antero Sarrael,Susan K Schultz,Laura L Boles Ponto,Hyungsub Shim,Karen Elizabeth Smith,Norman Relkin,Gloria Chaing,Lisa Raudin,Amanda Smith,Kristin Fargher,Balebail Ashok Raj
DOI: https://doi.org/10.1001/jamaneurol.2014.4829
Abstract:Importance: Cerebrospinal fluid (CSF) and positron emission tomographic (PET) amyloid biomarkers have been proposed for the detection of Alzheimer disease (AD) pathology in living patients and for the tracking of longitudinal changes, but the relation between biomarkers needs further study. Objective: To determine the association between CSF and PET amyloid biomarkers (cross-sectional and longitudinal measures) and compare the cutoffs for these measures. Design, setting, and participants: Longitudinal clinical cohort study from 2005 to 2014 including 820 participants with at least 1 florbetapir F-18 (hereafter referred to as simply florbetapir)-PET scan and at least 1 CSF β-amyloid 1-42 (Aβ1-42) sample obtained within 30 days of each other (501 participants had a second PET scan after 2 years, including 150 participants with CSF Aβ1-42 measurements). Data were obtained from the Alzheimer's Disease Neuroimaging Initiative database. Main outcomes and measures: Four different PET scans processing pipelines from 2 different laboratories were compared. The PET cutoff values were established using a mixture-modeling approach, and different mathematical models were applied to define the association between CSF and PET amyloid measures. Results: The values of the CSF Aβ1-42 samples and florbetapir-PET scans showed a nonlinear association (R2 = 0.48-0.66), with the strongest association for values in the middle range. The presence of a larger dynamic range of florbetapir-PET scan values in the higher range compared with the CSF Aβ1-42 plateau explained the differences in correlation with cognition (R2 = 0.36 and R2 = 0.25, respectively). The APOE genotype significantly modified the association between both biomarkers. The PET cutoff values derived from an unsupervised classifier converged with previous PET cutoff values and the established CSF Aβ1-42 cutoff levels. There was no association between longitudinal Aβ1-42 levels and standardized uptake value ratios during follow-up. Conclusions and relevance: The association between both biomarkers is limited to a middle range of values, is modified by the APOE genotype, and is absent for longitudinal changes; 4 different approaches in 2 different platforms converge on similar pathological Aβ cutoff levels; and different pipelines to process PET scans showed correlated but not identical results. Our findings suggest that both biomarkers measure different aspects of AD Aβ pathology.
What problem does this paper attempt to address?